OKYO Pharma Limited

DB:OK10 Rapporto sulle azioni

Cap. di mercato: €38.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

OKYO Pharma Gestione

Gestione criteri di controllo 2/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Gary Jacob

Amministratore delegato

UK£1.2m

Compenso totale

Percentuale dello stipendio del CEO29.2%
Mandato del CEO2.6yrs
Proprietà del CEOn/a
Durata media del management2.6yrs
Durata media del Consiglio di amministrazione2.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Gary Jacob rispetto agli utili di OKYO Pharma?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2023UK£1mUK£351k

-UK£13m

Dec 31 2022n/an/a

-UK£11m

Sep 30 2022n/an/a

-UK£7m

Jun 30 2022n/an/a

-UK£5m

Mar 31 2022UK£2mUK£266k

-UK£5m

Dec 31 2021n/an/a

-UK£5m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021UK£633kUK£62k

-UK£3m

Compensazione vs Mercato: Gary's total compensation ($USD1.53M) is above average for companies of similar size in the German market ($USD418.12K).

Compensazione vs guadagni: Gary's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Gary Jacob (76 yo)

2.6yrs

Mandato

UK£1,202,916

Compensazione

Dr. Gary S. Jacob, PhD, served as an Independent Director at Virpax Pharmaceuticals, Inc. since April 2020 until July 25, 2022. He had been an Independent Director of Cardiff Oncology, Inc. since February...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Gary Jacob
CEO & Executive Director2.6yrsUK£1.20mNessun dato
Michael Beck
Founderno dataNessun datoNessun dato
Keeren Shah
Chief Financial Officer3yrsNessun dato0%
€ 0
Rajkumar Patil
Chief Scientific Officer2.4yrsNessun dato0%
€ 0

2.6yrs

Durata media

65yo

Età media

Gestione esperta: OK10's management team is considered experienced (2.6 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Gary Jacob
CEO & Executive Director2.6yrsUK£1.20mNessun dato
Bernard Denoyer
Independent Non-Executive Director1.7yrsUK£46.20kNessun dato
Gabriele Marco Cerrone
Non-Executive Chairman2.6yrsUK£360.71kNessun dato
John Brancaccio
Independent Non-Executive Director3.2yrsUK£51.07kNessun dato
Jay Pepose
Member of Scientific Advisory Boardless than a yearNessun datoNessun dato
Willy Simon
Senior Independent Non-Executive Director7.8yrsUK£31.61kNessun dato
Napoleone Ferrara
Member of Scientific Advisory Board3yrsNessun datoNessun dato
Pedram Hamrah
Member of Scientific Advisory Boardno dataNessun datoNessun dato

2.6yrs

Durata media

72yo

Età media

Consiglio di amministrazione esperto: OK10's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.